RE: New target price reached. SP falls to 11’s23 Feb 2023 21:46
oj17 - the data, patents, the fact they can bung it straight onto a phase 3 trial etc are all worth something for those pharmas that might not want to start from scratch. How much, I’m honestly not sure. The market is saying not much at this moment in time.
Out of interest, if Synairgen won £50m on the lottery and could afford its own P3, what % chance do you think of it passing? And if it did pass, what do you think it would be worth then? Surely many multiple of what it is now, and I reckon worth a punt to someone.